Watch Ticker

Biofrontera Inc. Common Stock

Go to Biofrontera Inc. Common Stock Website

$1.02

0.02 (1.49%)

Live

Previous Close

$1.005

Day Range

$0.97 - $1.06

Previous Day Range

$1 - $1.1099

Market Cap

$10.5 million USD

Day Vol.

46106

Previous Day Vol.

76444

Currency

USD

Primary Exchange

Nasdaq

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which incl...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Andrew Barwicki - Biofrontera Inc. to Report Second Quarter FY 2025 Financial Results on August 13, 2025

Biofrontera Inc. will report Q2 2025 financial results on August 13, 2025, and has signed an agreement to acquire US assets related to Ameluz® and RhodoLED® from Biofrontera AG, backed by an $11 million investment.

Related tickers: BFRI, BFRIW.

Read Full Article

N/A - BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

Biofrontera Inc. has received a patent for a revised formulation of its drug Ameluz, extending patent protection until 2043. The company is also in negotiations with Biofrontera AG regarding a possible combination or adjustment of their license and supply agreement.

Related tickers: BFRI, BFRIW.

Read Full Article

Trending Tickers

Please sign in to view